SCHEMBL25906340

SCHEMBL25906340

Cc1cccc(-c2cccc(C(C)C)c2)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXRA P19793 2/20 0.45
▸ RXRB P28702 1/20 0.45
▸ RXRG P48443 1/20 0.45
▸ NR4A2 P43354 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ MDM4 O15151 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ TYR P14679 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ CA5A P35218 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ MDM2 Q00987 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9742882 0.84 ALOX12 (0.53) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL11423533 0.84 HTR7 (0.49) RXRARXRBRXRGNR4A2PTPN5
SCHEMBL18430840 0.82 CTSA (0.46) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL9742695 0.79 RXRA (0.51) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL9177215 0.79 RXRA (0.50) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL24721526 0.79 ALDH1A1 (0.55) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL9875662 0.78 LMNA (0.55) RXRARXRBRXRGNR4A2ALDH1A1
SCHEMBL1862854 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15ALOX12CA9TRPA1
SCHEMBL7140766 0.78 LMNA (0.61) RXRARXRBRXRGNR4A2TRPA1
SCHEMBL29362565 0.78 ALDH1A1 (0.50) ALDH1A1ALOX15ALOX12CA9TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC RXRA 2013/4885RXRB 1550/4885RXRG 1124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback